Anna Tobiasch: Should Fibrinogen and FXIII Be Restored Together After Severe Haemodilution?
Anna Tobiasch, Translational Scientist at Tirol Kliniken GmBH, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Thrombosis Research, adding:
“This project started with a simple question: if fibrinogen and FXIII decline together during severe haemodilution, should we also think about restoring them together?
Beyond the specific findings, this work highlights an idea that continues to fascinate me: haemostasis is not determined by isolated factors, but by their interactions and the emergent properties of the resulting clot.
Many thanks to everyone who contributed to the study and to the volunteers who participated.”
Title: Defining a fibrinogen-to-factor XIII replacement ratio in an in-vitro model of dilutional coagulopathy
Authors: Cristina Alomar-Dominguez, Marie Therese Bauer, Dietmar Fries, Ludwig Deinhart, Jennifer Gebetsberger, Mirjam Bachler, Johannes Bosch, Wolfgang Schobersberger, Martin Hermann, Christian Irsara, Luca Brunelli, Anna Katharina Tobiasch
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 22, 2026, 08:13How Long Does It Really Take to Recover from a Joint Bleed – EAHAD
-
Jul 22, 2026, 06:59Martina Böhm-Weigert: Supporting Precision Dosing in Hemophilia with Fitusiran
-
Jul 22, 2026, 05:26Richard Dalyai: Can AI Safely Refill Medications?
-
Jul 22, 2026, 05:15Annie Bauzon: What Is Anemia? – Microcytic, Normocytic and Macrocytic Types Explained
-
Jul 22, 2026, 05:05Rob Maloney: What If Hemophilia No Longer Needed Lifelong Treatment?
-
Jul 22, 2026, 05:01Melina Rodriguez: First FDA-Approved VWD Prophylaxis for All Ages
-
Jul 22, 2026, 04:59Martina Wolff: Advancing Knowledge Through Global Collaboration at ISTH 2026
-
Jul 22, 2026, 04:52G. Shellye Horowitz: Hemophilia A Genetics – Hemophilia A and Pregnancy
-
Jul 21, 2026, 23:43Shadi Tabibian: The Clinical Power of Patient Stories in Rare Bleeding Disorders